Analysis of adhesion molecule expression by tubular epithelial cells using urine immunocytology

R D Chan1, S M Greenstein, L Sablay

  • 1Department of Pediatrics, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, New York, USA.

Acta Cytologica
|May 1, 1995
PubMed

Insights

Urine tests can detect intercellular adhesion molecule-1 (ICAM-1) on kidney cells, helping to identify transplant rejection. This non-invasive method shows higher ICAM-1 levels during rejection and lower levels during recovery or stable function.

Area of Science:

  • Nephrology
  • Immunology
  • Transplantation

Background:

  • Renal tubular cells express intercellular adhesion molecule-1 (ICAM-1) during acute renal allograft rejection.
  • Assessing ICAM-1 expression is crucial for monitoring transplant health.
  • Current methods may be invasive or less sensitive.

Purpose of the Study:

  • To determine if urine immunocytology can estimate ICAM-1 expression on renal tubular cells.
  • To correlate urine ICAM-1 levels with clinical diagnosis and biopsy findings in renal transplant recipients.

Main Methods:

  • Collected urine samples from 31 renal transplant recipients with varying outcomes (ATN, rejection, stable function).
  • Utilized immunocytology with monoclonal antibodies to ICAM-1 on urinary sediment.
  • Corroborated findings with conventional and immunohistology on biopsy specimens.

Main Results:

  • Higher ICAM-1 expression on renal tubular cells in rejection (53.1%) compared to acute tubular necrosis (23.8%).
  • Decreased ICAM-1 levels observed in patients recovering from rejection.
  • Urine immunocytology results correlated well with immunohistology and clinical diagnosis.

Conclusions:

  • Urine immunocytology is a promising non-invasive method for monitoring ICAM-1 expression in renal transplant recipients.
  • This technique may aid in the early detection and management of renal allograft rejection.
  • Further studies can validate its clinical utility in transplant monitoring.